emodin has been researched along with cyclin d1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, XD; Li, L; Li, YZ; Liu, XN; Zhang, CY; Zheng, XZ | 1 |
| Chan, RY; Chan, SW; Li, WY; Yu, PH | 1 |
| Sui, JQ; Xie, KP; Xie, MJ; Zou, W | 1 |
| Karunagaran, D; Thacker, PC | 1 |
4 other study(ies) available for emodin and cyclin d1
| Article | Year |
|---|---|
Inhibitory effect of schisandrin B on gastric cancer cells in vitro.
Topics: Astragalus Plant; Cell Cycle; Cell Line, Tumor; Cyclin D1; Cyclooctanes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Emodin; Glucosides; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Lignans; Medicine, Chinese Traditional; Mitosis; Polycyclic Compounds; Polysaccharides; RNA, Messenger; Stomach Neoplasms; Time Factors | 2007 |
Emodin induces cytotoxic effect in human breast carcinoma MCF-7 cell through modulating the expression of apoptosis-related genes.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinoma; Cathartics; Cell Proliferation; Cyclin D1; DNA Breaks, Single-Stranded; DNA Fragmentation; Emodin; Fas Ligand Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; MCF-7 Cells; Myeloid Cell Leukemia Sequence 1 Protein; Neoplastic Stem Cells; Proto-Oncogene Proteins c-myc | 2013 |
Emodin inhibits breast cancer cell proliferation through the ERα-MAPK/Akt-cyclin D1/Bcl-2 signaling pathway.
Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cyclin D1; Emodin; Estrogen Receptor alpha; Estrogens; Female; Flow Cytometry; Humans; Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tumor Cells, Cultured | 2014 |
Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Topics: Antineoplastic Agents, Phytogenic; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Curcumin; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Drug Combinations; Drug Synergism; Emodin; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Laminin; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Protein Serine-Threonine Kinases; Proteoglycans; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad3 Protein; Smad4 Protein; Snail Family Transcription Factors; Transcription Factors; Transforming Growth Factor beta; Wnt Proteins | 2015 |